Oxford Science Enterprises
Status
ACTIVE
Global HQ
Oxford, United Kingdom
Countries of investment
- United Kingdom
Investment stages
- Seed
- Series A
- Growth
Industries
- Biotechnology
- Health Tech
- Deep Tech
About
Oxford Science Enterprises (OSE) is committed to building and scaling science-based startups emerging from the University of Oxford. With a focus on solving complex and fundamental problems in sectors such as biotechnology, healthcare, artificial intelligence, and engineered technologies, OSE partners with Oxford’s world-class researchers to commercialize groundbreaking science. The firm provides both the financial capital and operational expertise needed to take these ventures from the initial stages to growth and expansion, ensuring they are positioned for global success.
Oxford Science Enterprises (OSE) is committed to building and scaling science-based startups emerging from the University of Oxford. With a focus on solving complex and fundamental problems in sectors such as biotechnology, healthcare, artificial intelligence, and engineered technologies, OSE partners with Oxford’s world-class researchers to commercialize groundbreaking science. The firm provides both the financial capital and operational expertise needed to take these ventures from the initial stages to growth and expansion, ensuring they are positioned for global success.
Investment Thesis
Oxford Science Enterprises invests in science-led ventures emerging from the University of Oxford, following a conviction that solving global challenges—healthcare, energy, climate, and AI—requires deep collaboration between academia, entrepreneurs, and capital. The firm’s thesis focuses on long-horizon innovation with transformative potential. OSE identifies pioneering Oxford research, provides capital, recruits leadership talent, and builds operational capacity to translate scientific breakthroughs into scalable global companies.
Manager's Experience
Team includes senior scientists and investment experts with experience commercializing academic research and scaling science-led ventures.
Team
Ed Bussey- Chief Executive Officer
Jack Edmondson- Chief Investment Officer
Jim Wilkinson-Chief Financial Officer
Portfolio
Vaccitech
Oxford Quantum Circuits
First Light Fusion
Wild BioScience
PepGen
Osler Diagnostics
Evolito
Mind Foundry
OXE
Oxford PV